The 2nd Annual Biomarkers for Rare Non-Oncological Diseases Summit will unite biopharma, diagnostic and healthcare teams to advance the application of precision medicine in rare diseases beyond oncology.
Tackling critical challenges from early research through to late-stage market access, this meeting is the must-attend summit for industry-led insights in delivering novel treatments for patients in need.
Why Should You Attend?
Improving early validation, patient selection, clinical utility demonstration and reducing diagnostic timelines is critical to closing the gap on unmet clinical need for defined patient groups.
Built exclusively for biopharma, researchers and diagnostic developers, this meeting focuses specifically on the advancement of precision medicine in rare and defined patient groups. You can join fellow discovery, translational, clinical and commercial teams all dedicated to tackling the field’s most pressing challenges to radically improve patient outcomes and quality of care.